33
Themis Medicare
CEO |
Dr Dinesh Patel
|
![](http://biospectrumindia.ciol.com/images/content/2010/jun/Dinesh-Patel-%28Themis-Medica.jpg) |
Business |
Manufacturer and marketer of formulations and APIs of
synthetic origin
|
Start-up Year |
- |
Biotech Revenue |
Rs 90 crore |
Address |
11/12, Udyog Nagar, SV Road, Goregaon (West),
Mumbai-400 104
|
Tel |
+91-22-67607080 |
Fax |
+91-22-28746621
|
Website |
www.themismedicare.com |
Themis Medicare achieved a total turnover of Rs 90 crore for the
year ended March 31, 2010 as against Rs. 97.7 crores for the
previous corresponding year. Themis Medicare is a joint venture
pharmaceutical company, with Gedeon Richter Limited, Hungary. The
company in over three decades, has made its presence felt in
manufacturing and marketing of formulations and APIs of synthetic and
biotech origin. Though their first breakthrough product was Vitamin
B12, Themis moved on to manufacture synthetic APIs such as ethambutol
hydrochloride, pyrithioxine derivatives, methylcobalamin, propofol and
artemisinin derivatives.
Themis Medicare made its presence felt in the biotech market when
in 2004 it merged with Artemis Biotech. Artemis Biotech is involved in
biotechnology and fermentation activity. In the same year, Themis had
obtained COS for lovastatin and simvastatin which enabled them to sell
these statins in Europe. Lovastatin and Simvastatin today hold a
significant share of exports of the company.
34
Venkateshwara Hatcheries
Chair Person |
Anuradha Desai
|
![](/IMG/760/45760/anuradhadesaivenkateshwar.jpg) |
Business |
R&D, production and export of poultry and
diagnostics
|
Start-up Year |
1986 |
Biotech Revenue |
Rs 90 crore
|
Address |
Venkateshwara House, SN 114/A/2, Pune-Sinhagad Rd,
Pune-411030
|
Tel |
+91-20-24251530 |
Fax |
+91-20-24251077 |
Website |
www.venkys.com |
Venkateshwara Hatcheries, a part of the Pune-based VH group, posted a
revenue of Rs 90 crore for the financial year 2009-2010. As the first
company to embark on a process of developing the industry on scientific
lines, Venkateshwara Hatcheries occupies a special place in the Indian
poultry scene. It pioneered the concept of parent franchisee
operations, popularized cage farming, and introduced for the first time
in India, the concept of inactivated vaccines and combination vaccines.
The company has poultry operations in Maharashtra, Madhya Pradesh and
the southern states of India. Included in its portfolio are new
technology driven businesses like the egg powder plant in Hyderabad , a
100 percent export oriented unit, and wind energy farms on the
outskirts of Coimbatore.
The VH Group is entering Europe with a state-of-the-art poultry vaccine
manufacturing facility in Bassecourt, Switzerland. According to B
Venkateshwara Rao, Managing Director of the VH Group, if the approval
process goes according to company’s plan, the Swiss facility will be
operational by the end of 2011, and it will produce poultry vaccines
for the European, Asian and other regulated markets.
35
Vimta Labs
CEO |
Dr S P Vasireddi |
![](/IMG/761/45761/drspvasireddi.jpg) |
Business |
Contract research
|
Start-up Year |
1984 |
Biotech Revenue |
Rs 88.42 crore
|
Address |
142, IDA, Phase II, Cherlapally, Hyderabad - 500 051
|
Tel |
+91-40-2726 4141 |
Fax |
+91-40-2726 3657 |
Website |
www.vimta.com |
Vimta Labs is one of India’s leading contract research and testing
organization. Established in 1984 Vimta has an envious track record of
serving several market leaders across the globe. The company reported
biotech revenue of Rs 88.42 crore in 2009-20 as against Rs 81.60 crore
in 2008-09
The company is a team of 756 professionals comprising 479
scientists in various disciplines such as chemistry, pharma, medicine,
microbiology, molecular biology and informatics. The team is slated to
double in next three years. The company is a multi-site organization
with more than 300,000 sq ft world class laboratory facilities. The
technologies deployed at Vimta are current and leading edge, duly
validated. The company also provides full range of services to manage
clinical studies from study design to management to pre-approval
and post-marketing service.